B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PYGL

MOLECULAR TARGET

glycogen phosphorylase L

UniProt: P06737NCBI Gene: 58363 compounds

PYGL (glycogen phosphorylase L) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PYGL

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1alvocidib4.5291
2afegostat3.0420
3Quercetin0.691

About PYGL as a Drug Target

PYGL (glycogen phosphorylase L) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented PYGL interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PYGL inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.